{"id":831,"date":"2026-01-05T04:09:00","date_gmt":"2026-01-05T04:09:00","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=831"},"modified":"2026-02-06T16:36:37","modified_gmt":"2026-02-06T16:36:37","slug":"vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/nl\/vigilant-biosciences-werkt-samen-met-amp-als-distributeur-in-het-verenigd-koninkrijk\/","title":{"rendered":"Vigilant Biosciences\u00ae werkt samen met AMP als distributeur in het Verenigd Koninkrijk."},"content":{"rendered":"<p>[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033locked=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d global_colors_info=\u201d{ }\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.23.1\u2033 header_2_font_size=\u201d24px\u201d header_2_line_height=\u201d1.4em\u201d background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d custom_padding =\u201d25px||||false|false\u201d global_colors_info=\u201d{}\u201d]<\/p>\n<p><strong>Lakeway, Texas \u2014 5 januari 2026<\/strong>\u00a0\u2014 Vigilant Biosciences, een toonaangevende innovator en ontwikkelaar van oplossingen voor de vroege opsporing van mondkanker, kondigt met trots de samenwerking aan met AMP als distributeur van haar producten in het Verenigd Koninkrijk. Deze samenwerking is gericht op het vergroten van de toegang tot Vigilants baanbrekende diagnostische oplossingen binnen de medische gemeenschap.<\/p>\n<p>Als een vertrouwde leider in de medische sector brengt AMP een schat aan ervaring en een gevestigd netwerk in het Verenigd Koninkrijk met zich mee. Deze samenwerking zal Vigilant Biosciences in staat stellen haar innovatieve technologie\u00ebn voor kankerdetectie aan zorgverleners aan te bieden, waardoor de pati\u00ebntresultaten verbeteren door vroegtijdige interventie.<\/p>\n<p>&quot;We zijn enorm blij met de samenwerking met AMP&quot;, aldus Bill Brodie, CEO van Vigilant Biosciences. &quot;Hun expertise en streven naar uitmuntendheid in de medische sector sluiten perfect aan bij onze missie om effectieve oplossingen voor kankerdetectie te bieden. Samen zullen we zorgprofessionals de tools geven die ze nodig hebben om de pati\u00ebntenzorg te verbeteren.&quot;<\/p>\n<p>De geavanceerde diagnostische technologie van Vigilant richt zich op de vroege opsporing van mondkanker, waardoor tijdige interventie mogelijk is en de resultaten voor de pati\u00ebnt verbeteren. De samenwerking met AMP zal de verspreiding van deze essenti\u00eble hulpmiddelen vergemakkelijken, zodat meer zorgverleners de oplossingen van Vigilant in hun praktijk kunnen integreren.<\/p>\n<p>&quot;In 30 jaar klinische tandheelkunde hebben weinig innovaties de vroege screening op mondkanker wezenlijk versterkt. Het OraFusion-systeem van Vigilant doet precies dat door het visuele onderzoek aan te vullen met objectieve biomarkergegevens uit speeksel,&quot; aldus professor Bob Khanna, voorzitter van IAAFA.<\/p>\n<p>De samenwerking ging officieel van start in november, met plannen voor gezamenlijke trainingen en promotionele activiteiten om de producten van Vigilant te introduceren bij zorgprofessionals in het Verenigd Koninkrijk.<\/p>\n<p>Voor meer informatie over Vigilant Biosciences en de samenwerking met Aesthetic Medical Partnership kunt u terecht op vigilantbiosciences.com of amp-uk.co.uk.<\/p>\n<p><strong>Over Vigilant Biosciences<\/strong><\/p>\n<p>Vigilant Biosciences is een toonaangevende innovator en ontwikkelaar van oplossingen die artsen helpen bij de vroege opsporing van mondkanker. De BeVigilant\u2122-productlijn van Vigilant omvat point-of-care-testen die eenvoudig, nauwkeurig en kosteneffectief zijn, waardoor zorgverleners levens kunnen verbeteren door vroegtijdige interventie.<\/p>\n<p><strong>Over AMP<\/strong><\/p>\n<p>AMP levert regeneratieve medische technologie\u00ebn die esthetische en wellnessklinieken in het Verenigd Koninkrijk en Ierland helpen om consistente, hoogwaardige behandelresultaten te behalen. AMP biedt een portfolio van apparaten en biologische producten, ondersteund door uitgebreide training, marketing en service. Hierdoor kunnen klinieken, dankzij een samenwerkingsgerichte aanpak, vol vertrouwen en kosteneffectief populaire behandelingen introduceren. AMP werkt samen met zorgverleners om de pati\u00ebntloyaliteit te versterken en duurzame bedrijfsgroei te ondersteunen.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Lakeway, TX \u2014 January 5, 2026\u00a0\u2014 Vigilant Biosciences, a leading innovator and developer of solutions that assist in the early detection of oral cancer, is excited to announce its partnership with AMP as a distributor of its products in the United Kingdom. This collaboration aims to expand access to Vigilant\u2019s groundbreaking diagnostic solutions within the [&hellip;]<\/p>","protected":false},"author":9,"featured_media":834,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/nl\/vigilant-biosciences-werkt-samen-met-amp-als-distributeur-in-het-verenigd-koninkrijk\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Patient Resources Understanding the Risk of Oral CancerThe Impact of Oral Cancer In the US alone, oral cancer kills an average one person per hour, 24 hours per day.1Oral cancer is a global challenge with more than 657,000 cases and nearly 330,000 deaths each year1Worldwide 5-year survival rate is only 50% due to delayed intervention [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/nl\/vigilant-biosciences-werkt-samen-met-amp-als-distributeur-in-het-verenigd-koninkrijk\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-05T04:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-06T16:36:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/AMp-Logo-press-release.png\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"413\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Rachel LaBreck\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rachel LaBreck\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/\"},\"author\":{\"name\":\"Rachel LaBreck\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753\"},\"headline\":\"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK\",\"datePublished\":\"2026-01-05T04:09:00+00:00\",\"dateModified\":\"2026-02-06T16:36:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/\",\"name\":\"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2026-01-05T04:09:00+00:00\",\"dateModified\":\"2026-02-06T16:36:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753\",\"name\":\"Rachel LaBreck\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g\",\"caption\":\"Rachel LaBreck\"},\"url\":\"https:\/\/vigilantbiosciences.com\/nl\/author\/rachel-labreck\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK - Vigilant Biosciences\u00ae","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/nl\/vigilant-biosciences-werkt-samen-met-amp-als-distributeur-in-het-verenigd-koninkrijk\/","og_locale":"nl_NL","og_type":"article","og_title":"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK - Vigilant Biosciences\u00ae","og_description":"Patient Resources Understanding the Risk of Oral CancerThe Impact of Oral Cancer In the US alone, oral cancer kills an average one person per hour, 24 hours per day.1Oral cancer is a global challenge with more than 657,000 cases and nearly 330,000 deaths each year1Worldwide 5-year survival rate is only 50% due to delayed intervention [&hellip;]","og_url":"https:\/\/vigilantbiosciences.com\/nl\/vigilant-biosciences-werkt-samen-met-amp-als-distributeur-in-het-verenigd-koninkrijk\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2026-01-05T04:09:00+00:00","article_modified_time":"2026-02-06T16:36:37+00:00","og_image":[{"width":750,"height":413,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/AMp-Logo-press-release.png","type":"image\/png"}],"author":"Rachel LaBreck","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Rachel LaBreck","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/"},"author":{"name":"Rachel LaBreck","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753"},"headline":"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK","datePublished":"2026-01-05T04:09:00+00:00","dateModified":"2026-02-06T16:36:37+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/"},"wordCount":488,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/","url":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/","name":"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2026-01-05T04:09:00+00:00","dateModified":"2026-02-06T16:36:37+00:00","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/vigilant-biosciences-partners-with-amp-as-a-distributor-in-the-uk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"Vigilant Biosciences\u00ae Partners with AMP as a Distributor in the UK"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753","name":"Rachel LaBreck","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g","caption":"Rachel LaBreck"},"url":"https:\/\/vigilantbiosciences.com\/nl\/author\/rachel-labreck\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/posts\/831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/comments?post=831"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/posts\/831\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/media\/834"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/media?parent=831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/categories?post=831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/tags?post=831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}